Treatment of Solid Tumors With Intratumoral Hiltonol® (Poly-ICLC)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Melanoma|Squamous Cell Carcinoma of the Head and Neck|Squamous Cell Carcinoma of the Skin|Sarcoma of the Skin|Basal Cell Cancer of the Skin|Breast Cancer
Interventions: DRUG: Poly-ICLC
Sponsor: Nina Bhardwaj
Collaborators: Oncovir, Inc.